Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

A novel nanotechnology approach can reduce HIV treatment dosages and improve drug delivery, according to a study.

A New Zealand woman who was intentionally infected with HIV and was the center of a high profile criminal case faces down numerous challenges related to the virus.

Gregory R. Morris, chief commercial officer at VirMedica, discusses hurdles with the use of eAccess technology in specialty pharmacy.

Scientists utilized nanotechnology to improve HIV treatments.

Recombinant shell nanoparticles could deliver drugs straight to cancer cells.

Sarcopenia identified as an independent risk factor.

Top news of the day from across the health care landscape.

Fibroblasts in the gastrointestinal tract help HIV infect immune cells.

Drug may offer an effective alternative to chemotherapy for patients with leukemia.

Combination treatment helped increase invasive disease-free survival in patients with an aggressive type of early breast cancer.

Analysis confirms the safety and efficacy of palliative radiation therapy for painful bone metastases.

Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses how specialty pharmacies can help patients access high cost specialty drugs.

Top news of the day from across the health care landscape.

Gilead’s antiretroviral medication associated with the increased risk of fracture in patients with HIV.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how collaborative care programs among providers can benefit patients undergoing treatment.

MiniMed 670G significantly reduced HbA1c levels in adolescents and adults with type 1 diabetes.

Investigational drug treats patients with relapsed or refractory AML with an isocitrate dehydrogenase 2 mutation.

Top news of the day from across the health care landscape.

Investigational MS drug lowers the relapse rate during a phase 3 clinical trial.

G-CSF promotes regeneration of sperm cells in cancer patients.

A majority of glioblastomas change their genomic profile during therapy, new research finds.

Targeting the interactions between neurons and cancer cells may be a powerful strategy in future cancer treatments.

Alternating gut microbiota in mice causes hypertension.

Top news of the day from across the health care landscape.

One-fourth of standard dose with low-fat meal as effective as standard dose.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.

The smallest Cas9 gene editing technique has been developed thus far.

New technology can predict which patients will achieve remission and which will relapse.

Top news of the day from across the health care landscape.